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DOI 10.1016/j.ccr.2010.11.010SUMMARYN-a-acetyltransferase 10 protein, Naa10p, is an N-acetyltransferase known to be involved in cell cycle
control. We found that Naa10p was expressed lower in varieties of malignancies with lymph node metastasis
compared with non-lymph nodemetastasis. Higher Naa10p expression correlates the survival of lung cancer
patients. Naa10p significantly suppressed migration, tumor growth, and metastasis independent of its enzy-
matic activity. Instead, Naa10p binds to the GIT-binding domain of PIX, thereby preventing the formation of
the GIT-PIX-Paxillin complex, resulting in reduced intrinsic Cdc42/Rac1 activity and decreased cell migra-
tion. Forced expression of PIX in Naa10-transfected tumor cells restored themigration andmetastasis ability.
We suggest that Naa10p functions as a tumor metastasis suppressor by disrupting the migratory complex,
PIX-GIT- Paxillin, in cancer cells.INTRODUCTION
N-a-acetyltransferase 10 (Naa10, also known as ARD1) protein
is the catalytic subunit of the major N-terminal acetyltransferase
(NAT) complex, NatA, consisting of Naa10p and human Naa15p
(also known as NATH). Together, they mediate the N-terminal
acetylation of nascent polypeptides that emerge from ribosomesSignificance
The role of Naa10p in human cancers is elusive. In the present
with less metastasis to lymph nodes and better prognosis o
through a previously undescribed mechanism of binding to t
membrane and reducing subsequent Cdc42/Rac1 activity. An
of Naa10p on cell migration and tumor metastasis. Our study
target for tumor metastasis, but also identifies Naa10p as a
Paxillin.
218 Cancer Cell 19, 218–231, February 15, 2011 ª2011 Elsevier Inc.after translation (Arnesen et al., 2009). The specificity of Naa10p
is highly conserved from yeasts to humans (Arnesen et al., 2005,
2009; Park and Szostak, 1992; Whiteway and Szostak, 1985).
Ard1-D yeast mutants and Naa10p knockdown cells show
a similar defect in cell growth (Fisher et al., 2005; Lim et al.,
2006; Whiteway and Szostak, 1985). Recently, Naa10p expres-
sion was reported in breast, cervical, thyroid, and colorectalstudy, we found that elevated Naa10p levels are associated
f cancer patients. Naa10p inhibits cell migration/invasion
he PIX protein, thereby preventing its translocation to the
increased expression of PIX reversed the suppressive effect
not only highlights the potential of Naa10p as a therapeutic
regulatory component of the migration complex PIX-GIT-
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Naa10p Suppresses Cancer Metastasis through PIXcancer (Fluge et al., 2002; Ren et al., 2008; Yu et al., 2009).
However, the correlation between Naa10p and important clinical
parameters, as well as the exact action of Naa10p in cancer cells
remain unclear.
During cell migration, actin filaments organize into a branched
network at the leading edge, and the filaments undergo rapid
and coordinated assembly and/or disassembly to drive the
edge forward (Pollard and Borisy, 2003). The concerted regula-
tion of these events is mediated by a complex temporal and
spatial interplay of Rho GTPases and their regulatory proteins,
including guanine nucleotide exchange factors (GEFs),
GTPase-activating proteins (GAPs), and guanine nucleotide
dissociation inhibitors (GDIs) (Gulli and Peter, 2001). The
p21-activated kinase (PAK)-interacting exchange factor (PIX)
family members have been shown to act as GEFs mediating
the activation of Rac1 and Cdc42. In addition, PIX proteins can
serve as scaffold proteins by binding to Paxillin and G protein-
coupled receptor kinase-interacting (GIT) proteins, the GAP for
Arf GTPases, resulting in translocation of the GIT-PIX-Paxillin
complex to a focal adhesion complex and membrane ruffles
(Botrugno et al., 2006; Hoefen and Berk, 2006; Webb et al.,
2002). The PIX complex serves as a multifunctional protein
binding platform that plays an important role in the control of
cell shape, polarity, and focal adhesion turnover (Frank and
Hansen, 2008; Hoefen and Berk, 2006; Jones and Katan, 2007;
Zhang et al., 2005). PIX proteins were found to be highly
expressed in glioma (Yokota et al., 2006) and breast cancer
(Ahn et al., 2003). Both PIX and GIT were found to increase the
migration potentials of a variety of cancer cells (Lee et al.,
2005; Manabe et al., 2002). Recently, the GEF activity of PIX
was found to be regulated by phosphorylation at specific sites
and its binding interactions (Chahdi et al., 2005; Shin et al.,
2002, 2004). Binding of PAK and GTP-bound Cdc42 stimulates
aPIX GEF activity (Baird et al., 2005; Feng et al., 2004), while
binding of 14-3-3b inhibits bPIX GEF activity (Chahdi and Soro-
kin, 2008). Nonetheless, the regulation of PIX localization and
the formation of the PIX-GIT-Paxillin complex remain unknown.
Here, we investigated whether Naa10p expressed differen-
tially in tumors of different progression status and the involve-
ment of Naa10p in the regulation of PIX-GIT complex formation
and function.
RESULTS
Expression of Naa10p Inversely Correlates with Lymph
Node Metastasis and Survival of Cancer Patients
To elucidate the clinical relevance of Naa10p in cancer patients,
we analyzed a cohort of 318 lung cancer specimens using immu-
nohistochemical analysis (IHC) with Naa10p-specific antibody.
The antibody specificity was defined and is shown in Figure S1A
available online. Naa10p expression was detected in normal lung
epithelium (Figure 1A), lung adenocarcinomas (Figures 1B and
1C), and in squamous cell carcinomas (Figures 1D and 1E).
Naa10p was found to be expressed predominantly in the
cytosol, and rarely in the nucleus. Naa10p expression was
inversely correlated with lymph nodemetastasis (Table 1). Semi-
quantitative analysis by immunoblotting of an independent
cohort of lung adenocarcinoma (N = 89) also confirms this corre-
lation (Figure 1F). To study the significance of Naa10p in lymphCnode metastasis, we collected 15 sets of individually matched
samples from primary tumors and lymph node metastases.
Strikingly, in 13 out of 15 patients, the Naa10p levels were signif-
icantly reduced in the lymph node metastatic tumors compared
with primary lung tumors (Figures 1G and 1H, p < 0.01). Notably,
the early stage tumor without lymph node involvement had the
highest level of Naa10p expression (case 1 in Figure 1G). Similar
results were also found in breast (n = 53) and gastric cancer
tissues (n = 92) by comparing patients with or without lymph
node metastasis (Figures S1E to S1G). Naa10p expression
was significantly correlated with both relapse-free survival and
overall survival of lung cancer patients (Figure 1I; Figures S1B–
S1D). Taken together, the above clinical data indicate that down-
regulation of Naa10p is a critical event in tumor progression.
Naa10p Suppresses Mobility of Cancer Cells
Our clinical findings suggest that Naa10p may play a role in the
invasiveness and metastatic ability of tumor cells. We next eval-
uated the function of Naa10p in cell migration, which is the most
fundamental step of tumor invasion and metastasis. siRNAs
knockdown of Naa10p significantly increased cell motility in
lung cancer cell lines with limited transwell migration ability
(CL1-0, H661, PC14, and H1435) (Figure 2A; Figure S2A). To
exclude the possibility of off-target effects, we reintroduced
Naa10p in to the cells, bringing themigration level back to normal
(Figure 2B). In comparison, overexpression of Naa10p signifi-
cantly decreased cell migration in highly migratory lung cancer
cell lines CL1-5, H1355, and A549 (Figure 2C). These results
were also confirmed in a series of breast, ovarian, and gastric
cancer cell lines (Figures S2B). Similar results were obtained in
cell tracking assays (Figure S2C). Naa10p affected the invasion
ability and migration of cancer cells to a similar extent (Fig-
ure S2D). However, we did not detect any significant difference
in matrix metalloproteinase levels among these cells (data not
shown). Thus, the effect of Naa10p on cell invasiveness was
largely attributable to migration inhibition. In addition, manipula-
tion of Naa10p expression had no significant effect on cell
proliferation (Figure S2E). Furthermore, the distribution of focal
adhesions was altered in the Naa10p-knockdown AGS cells as
detected by paxillin-specific antibody. The control AGS cells
displayed an immotile phenotype with random distribution of
paxillin around the cell, while most of the Naa10p-knockdown
cells displayed one or more pseudopodia-like membrane protru-
sions, which may explain the increase in migration ability. The
control CL1-5 cells had most of their focal adhesions in the
puncta of membrane protrusions, while Naa10p-expressing
cells displayed a more random distribution (Figure 2D). Taken
together, these results indicate Naa10p plays important roles
in cell migration.
Acetyltransferase Activity of Naa10p Is Not Necessary
for Regulating Cell Migration
Naa10p exerts its acetyltransferase activity through collabora-
tion with Naa15p (Arnesen et al., 2005). To determine whether
Naa10p affects cell migration in a Naa15p-dependent manner,
we cotransfected Naa10p and Naa15p into A549 cells and
measured their relative migration abilities. Comparing to the
known cooperative role of Naa10p and Naa15p in other
cellular functions (Arnesen et al., 2005; Asaumi et al., 2005;ancer Cell 19, 218–231, February 15, 2011 ª2011 Elsevier Inc. 219
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Figure 1. Naa10p Is Expressed in Cancers and Inversely Correlates with Lymph Node Metastasis and Survival of Cancer Patients
(A–E) Naa10p levels in representative normal and tumor tissues. Immunohistochemistry using the rabbit anti-Naa10p antibody (GB-10511, Genesis Biotech) of
normal lung alveolar tissue (A), lung adenocarcinoma tissues (B and C) and lung squamous cell carcinoma tissues (D and E). (B) and (D) are examples of high
Naa10p expression; (C) and (E) are example of low Naa10p expression. Scale bars, 50 mm in (A)–(E).
(F) Correlation between Naa10p expression levels and lymph node metastasis status. A total of 89 lung adenocarcinoma specimens were analyzed by immuno-
blotting. After normalization with b-actin, the average expression level was recognized in arbitrary units (AU) 1. Low Naa10p expression (AU < 0.45) is depicted as
red columns, whereas high Naa10p expression (AU > 0.45) is depicted as blue columns. *p < 0.05.
(G) Representative microphotographs of immunohistochemical staining of Naa10p in matched specimens of primary lung tumor and lymph node metastases. T,
tumor cells in lymph node. Scale bars, 100 mm.
(H) Plot representation of scores according to cytoplasmic immunohistochemical expression of Naa10p in primary lung tumors related to the lymph node metas-
tases. The scores are calculated by intensity 3 percentage of stained cells.
(I) Kaplan-Meier plot of overall and disease-free survival of 318 patients with lung carcinomas stratified by Naa10p expression level. A log rank test was used to
show differences between groups.
See also Figure S1.
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Table 1. Clinicopathologic Characteristics of Patients with Low and High Expression of Naa10p in 318 Lung Cancer Patients
Characteristic
Low Expression
(score 0–1), N = 199
High Expression
(score 2–3), N = 119 p Value
Age (mean ± SD) (in years) 61.76 ± 11.36 61.77 ± 10.99 0.99a
Sex, no. of patients
—Male 120 67 0.48b
—Female 79 52
Stage,c no. of patients
—I-II 107 78 0.04b
—III-IV 92 41
Tumor status,c no. of patients
—T1-T2 161 101 0.37b
—T3-T4 38 18
Lymph nodal status,c no. of patients
—N0 89 69 0.02b
—N1-N3 110 50
Metastasis,c no. of patients
—M0 164 98 0.99b
—M1 35 21
Histology, no. of patients
—Adenocarcinoma 131 84 0.38b
—Nonadenocarcinoma 68 35
Median survival (in months) 61.2 29.8 0.0044d
a p value was measured with student’s t test.
b p values were derived with Pearson chi-square tests.
c The tumor stage, tumor status, lymph node status, and metastasis were classified according to the international system for staging lung cancer.
d p values was derived with log rank test. All statistical tests are two sided. SD, standard deviation.
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Naa10p Suppresses Cancer Metastasis through PIXLim et al., 2006), Naa10p-mediated suppression of migration
was not accelerated in the presence of Naa15p (Figure 2E,
column 4 versus column 2). To confirm whether the acetylation
activity of Naa10p was involved in regulating cell mobility, we
generated a mutant Naa10p construct, Naa10p-R82A, which
had lost its ability to associate with acetyl-CoA, and therefore
exhibited low acetyltransferase activity (Asaumi et al., 2005) as
confirmed by [3H]-acetate incorporation assay using PCNP,
a known Naa10p N-acetylation target (Arnesen et al., 2009), as
substrate (Figure S2F). Interestingly, no difference in the
migration ability was detectable between Naa10p- and
Naa10p-R82A-transfected A549 cells (Figure 2E). Similarly,
overexpression or shRNA inhibition of Naa11p, a homolog of
Naa10p that displays similar acetyltransferase activity, did not
affect cell migration (Figures 2F and 2G). Taken together, these
results suggest that Naa10p regulates cell migration through
a mechanism independent of Naa15p and its intrinsic acetyl-
transferase activity.
Suppression of Tumor Growth and Metastasis
by Naa10p
We next examined the in vivo effects of Naa10p expression on
tumor growth and metastasis. Control CL1-5 cells (CL1-5/vec)
subcutaneously injected into NOD-SCID mice formed large
tumors after 4 weeks. In contrast, mice injected with CL1-5 cells
ectopically expressing Naa10p (CL1-5/Naa10) or Naa10p-R82A
(CL1-5/R82A) grew small tumors (Figure S3A). The ability ofCthese tumors to retain the expression of Naa10p or Naa10p-
R82A was examined (Figure S3B). No metastases were macro-
scopically visible in the lungs of these mice; longer monitoring
times would be needed to observe such secondary tumors.
However, the mice had to be sacrificed after 4 weeks due to
large subcutaneous tumors according to the guidelines of the
Animal Ethic Committee. To circumvent this problem, we iso-
lated cells from the lung tissue at the endpoint of the study and
cultured them in the presence of G418 for 2 weeks to select for
transfected cells. The control cells formed 1–60 colonies per
lung compared with 0–7 in the CL1-5/Naa10 group and 0–4 in
the CL1-5/R82A group (Figure S3C). PCR analysis of human-
specific Alu element further supported these findings, in that
the Naa10p and Naa10p-R82A groups had relatively few human
cancer cells in the lungs compared with the control group
(Figure S3D).
To further evaluate the role of Naa10p in metastasis, we used
murine breast cancer cell line 4T1, which shows frequent lung
metastasis after orthotopic fat pad inoculation. In order to avoid
the effects of different sizes of primary tumors, we surgically
removed fat pad tumors after the tumor size exceed 1 cm3.
Mice were sacrificed after 2 weeks and lung metastases were
examined by macroscopic observation and luciferase activity.
Naa10p or Naa10p-R82A expression significantly diminished
lung metastases (Figures 3A and 3B). Furthermore, axillary
lymph node enlargements were found to be decreased in the
Naa10p and Naa10p-R82A groups (Figure 3C). We alsoancer Cell 19, 218–231, February 15, 2011 ª2011 Elsevier Inc. 221
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Figure 2. Naa10p Suppresses Mobility of
Cancer Cells
(A) Transwell migration assay of lung cancer cell
lines including CL1-0, H661, PC14, and H1435
transfected with either a pool of four control siRNA
or Naa10p siRNA. The fold difference represents
the mean of triplicate experiments compared
with control siRNA-treated cells. *p < 0.05.
(B) Transwell migration assay of CL1-0 cells trans-
fected with two different Naa10 siRNAs targeting
50-UTR of Naa10 mRNA with or without cotrans-
fected with Naa10-V5 as indicated. The fold
difference represents the mean of triplicate exper-
iments compared with control siRNA-treated cells.
*p < 0.05.
(C) Transwell migration assays of lung cancer cell
lines including CL1-5, H1355, and A549 either
transfected with control vector or Naa10p-V5.
The fold difference represents the mean of tripli-
cate experiments compared with control cells.
*p < 0.05.
(D) The cellular morphology is altered in cells with
overexpressed or downregulated Naa10p expres-
sion. CL1-5 and AGS cells were transfected with
either Naa10p-V5, Naa10p shRNA, or their respec-
tive controls, as indicated. Cells were fixed and
stained for F-actin (green) and paxillin (red). Nuclei
were counterstained with DAPI (blue). Scale bars,
20 mm.
(E) A549 cells were transfected with NATH-Myc,
Naa10p-V5, and R82A-V5 either alone or in combi-
nation with each other, as indicated and subjected
to transwell migration assay. The fold difference
represents the mean of triplicate experiments
compared with control cells. *p < 0.05.
(F) CL1-5 cells were transfected with Naa10-V5 or
Naa11-V5, and the transwell migration assay was
performed. Each data point is representative as
mean of triplicate experiments. *p < 0.05.
(G) CL1-0 cells were infected with lentivirus
carrying shRNA for either Naa10 or Naa11 and
subjected to transwell migration assay. RT-PCR
was performed using Naa10- or Naa11-specific
primers. The fold difference represents the mean
of triplicate experiments compared with control
cells. *p < 0.05. Error bars indicate SD.
See also Figure S2.
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Naa10p Suppresses Cancer Metastasis through PIXexamined the presence of 4T1 cells in the peripheral blood and
found significantly fewer cell numbers in the Naa10p and
Naa10p-R82A groups (Figure 3D). We also examined the
expression of Naa10p or Naa10p-R82A in colonies derived
from either group to see if these colonies retained the expres-
sion of Naa10p or Naa10p-R82A. In all of the colonies, only
four from the ten member Naa10p group and one from the
nine member Naa10p-R82A group still expressed Naa10p/
Naa10p-R82A (Figure S3E). In order to examine lung coloniza-
tion, lung adenocarcinoma cell line A549 was injected into the
lateral tail vein of NOD-SCID mice. Six weeks postinjection,
significantly lower metastatic nodules were formed in the
A549/Naa10 group compared with the A549/vector group (Fig-
ure S3F). Our data indicate that Naa10p expression suppresses
tumor cell growth, extravasation, intravasation, and lung
colonization.222 Cancer Cell 19, 218–231, February 15, 2011 ª2011 Elsevier Inc.Naa10p Alters the Activation Status of Cdc42 and Rac1
Rho family GTPases such as Rac1, Cdc42, and RhoA control
actin dynamics and play key roles in cell migration. To determine
whether the function of Naa10p in cell migration is mediated
through the Rho family of GTPases, we compared the levels of
GTP-bound RhoA, Rac1, and Cdc42 in the CL1-0 and CL1-5
cell lines. CL1-5 cells transfected with Naa10p or Naa10p-
R82A resulted in lower levels of GTP-bound Rac1 and Cdc42
when compared with controls, while CL1-0 cells transfected
with a siRNA pool directed against Naa10p resulted in higher
levels of GTP-bound Rac1 and Cdc42 (Figure 4A). This result
was further confirmed by using individual siRNA from the pool
to knock down Naa10p and observed similar elevation of GTP-
bound Rac1 and Cdc42 (Figure S4A). To exclude the possibility
of off-target effects, we reintroduced Naa10p in to the cells,
bringing the GTP-bound Rac1 and Cdc42 level back to normal
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Figure 3. Naa10p Suppresses Metastatic Coloni-
zation in Animal Models
(A) Lungs were isolated and examined after spontaneous
metastasis assay. Upper panel: representative luciferase
activity image. Middle panel: photos of lungs. Lower panel:
H & E staining of lungmetastatic tumors. Scale bar, middle
panel: 5 mm, lower panel: 100 mm.
(B) Upper panel: number of surface metastases in lungs of
mice. Lower panel: quantification of luciferase activity.
Photon counting analysis of lung nodules was performed
after inoculation with luciferin. *p < 0.05; n = 7 mice per
group.
(C) Macroscopic analysis of axillary lymph nodes. Lymph
nodewas photographed andweighted after removal. Error
bars indicate SD. Scale bar, 0.5 cm. *p < 0.05.
(D) Naa10p reduced intravasation of 4T1 cells. The intrava-
sation of tumor cells was determined from the blood
culture of mice. Number of colonies was counted after
grown in G418-containing media for 2 weeks.
See also Figure S3.
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Naa10p Suppresses Cancer Metastasis through PIX(Figure S4B). The levels of GTP-bound RhoA, however, remained
unchanged. To elucidate the importance of decreased
GTP-bound Rac1 and Cdc42 in Naa10p-regulated cell mobility,
we expressed constitutively active Rac1 (Rac1V12) and Cdc42
(Cdc42V12) in CL1-5 cells with stable Naa10p expression. Both
Rac1V12 and Cdc42V12 were found to be able to reverse the
effect of Naa10p to bring the migration ability back to normal
levels (Figure 4B). Furthermore, dominant negative Rac1
(Rac1N17) and Cdc42 (Cdc42N17) suppressed the migration
ability induced by shRNA-mediated Naa10p knockdown in
MCF-7 cells (Figure 4C). These data suggest that Naa10p regu-
lation of cell migration depends on its ability to modulate Rac1
and Cdc42 activity.
Naa10p Interacts with bPIX
Our results suggest that Naa10p regulates cell mobility in an
acetyltransferase-independent manner, possibly through the
activation of Rac1 and Cdc42. However, we did not detect any
direct association between Naa10p and Rac1 or Cdc42 (data
not shown), which indicates that other binding partners such
as GEFs or GAPs are required for Naa10p’s regulation of
Cdc42 and Rac1 activity.
To investigate the Naa10p-dependent regulation of Rac1 and
Cdc42, we performed coimmunoprecipitation with V5-tagged
Naa10p and known regulators of Rac1 and Cdc42 activity. We
found that the PIX proteins (aPIX and bPIX) were able to bindCancer Cell 19, 218to Naa10p. The PIX proteins are a group of
GEFs known to regulate both Rac1 and
Cdc42. In contrast, TIAM1, another GEF
specific for Rac1/Cdc42, did not associate
with Naa10p (Figure 5A). Previous studies have
shown that aPIX is expressed primarily in hema-
topoietic cells and muscle, whereas bPIX is
ubiquitously expressed (Koh et al., 2001; Man-
ser et al., 1998). In agreement with these find-
ings, we detected the interaction between
endogenous Naa10p and bPIX (Figure 5B) by
coimmunoprecipitation. In addition, in vitropull-down assays using recombinant GST-Naa10p (generated
from Escherichia coli) and in vitro-transcribed/translated bPIX
further suggested a direct association between Naa10p and
bPIX (Figure 5C). A similar association occurred between
Naa10p and aPIX (Figure 5C). Moreover, Naa11p and Naa15p
failed to coimmunoprecipitate with aPIX or bPIX, implying
a highly specific interaction between Naa10p and a/bPIX
(Figures S5A and S5B).
The Naa10p protein contains a conserved acetyltransferase
domain. It was also reported that residues 1–58 in the N terminus
were responsible for the Naa15p interaction, and that the last 50
residues in the C terminus mediated interaction with b-amyloid
precursor protein (Asaumi et al., 2005). To characterize the
mechanism by which Naa10p and aPIX/bPIX interact, a series
of expression constructs were generated for the wild-type full-
length and truncated mutants of Naa10p (Figure 5D). The aPIX
and bPIX could be pulled down by full-length Naa10p, N-terminal
deleted Naa10p (residues 59–235), and the Naa10p-acetyltrans-
ferase domain (residues 60–130), but not by C-terminal Naa10p
(residues 131–235) (Figure 5E; Figure S5C). These results indi-
cate that the acetyltransferase domain is the primary site for
aPIX and bPIX interaction.
Tomap the Naa10p binding region of bPIX, we used a series of
bPIX truncation mutants (Figure 5D). Coimmunoprecipitation
results revealed that all constructs with a GIT-binding domain
(GBD) interacted with Naa10p (Figure 5F). This domain is–231, February 15, 2011 ª2011 Elsevier Inc. 223
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Figure 4. Naa10p Alters the Activation
Status of Cdc42/Rac1
(A) CL1-5 and CL1-0 cells were transfected with
Naa10-V5, R82A-V5, Naa10 siRNA, or their corre-
sponding controls as indicated. GTP-Cdc42 and
Rac1 were assayed using GST-PBD. GTP-RhoA
was assayed using GST-TBD. Each experiment
was repeated three times and the amounts of
GTP-Cdc42/Rac1/RhoA were analyzed by densi-
tometer. Upper panel: representative blot of the
Cdc42/Rac1/RhoA activity assay. Lower panel:
quantification and statistical analysis of the
GTP-Cdc42/Rac1/RhoA. *p < 0.05.
(B) Cell migration of CL1-5 cells transiently trans-
fected with either Naa10-V5 or control vector, or
together with Myc-tagged Cdc42V12 or Rac1V12.
The fold difference represents the mean of tripli-
cate experiments compared with control cells.
*p < 0.05.
(C) Cell migration of MCF-7 cells infected by lenti-
virus carrying either Naa10 shRNA or control lucif-
erase shRNA, either alone or after transfectionwith
Myc-tagged Cdc42N17 or Rac1N17. The fold differ-
ence represents themean of triplicate experiments
compared with luciferase shRNA infected cells.
*p < 0.05. Error bars indicate SD.
See also Figure S4.
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Naa10p Suppresses Cancer Metastasis through PIXconserved between aPIX and bPIX, and as expected, we found
that Naa10p and aPIX interacted in the same fashion (Fig-
ure S5D). Taken together, these results show that the Naa10p
acetyltransferase domain interacts with the aPIX/bPIX GIT-
binding domain. We next examined whether bPIX was acety-
lated by Naa10p. Since their interaction was independent of
Naa15p, bPIX was less likely to be N-a-acetylated by Naa10p.
Naa10p has also been reported to function as an N-3-acetyla-
transferase (Lim et al., 2006, 2008). Thus, we examined whether
Naa10p mediated N-3-acetylation of bPIX. bPIX were immuno-
precipitated from cells with Naa10p overexpression or knock-
down by siRNA, and the acetylated bPIX was detected by
antibodies against acetyl lysine. However, we could not detect
any acetylated bPIX even with three different antibodies (Fig-
ure S5E), indicating that Naa10p did not N-3-acetylated bPIX.
Naa10pDisrupts the InteractionwithGIT to Inhibit Rac1/
Cdc42 Activation and Cell Migration
Our results indicate that Naa10p regulates cellular migration
through the interaction with PIX. To further explore this possi-
bility, we transfected Naa10p either alone or in combination
with bPIX in 293T cells. As expected, single transfection of
bPIX resulted in increased Cdc42 and Rac1 activity. Interestingly
dual transfection of Naa10p and bPIX only caused a modest
increase of the activity compare to the untransfected control
(Figure 6A).224 Cancer Cell 19, 218–231, February 15, 2011 ª2011 Elsevier Inc.Wealso conducted single or dual trans-
fection (as noted in Figure 6B) in the highly
migratory cell line CL1-5. Interestingly,
individual transfection of GIT1, aPIX, or
bPIX was sufficient to increase cell migra-
tion, while single transfection of Naa10presulted in a significant decrease of cell migration. In consistence
with the above findings, dual transfection of Naa10p in combina-
tion with GIT1, aPIX or bPIX resulted in similar migration
compared with the untransfected control (Figure 6B). Hence
overexpression of Naa10p is sufficient to prevent PIX dependent
activation of Cdc/Rac activity and cell migration.
Similary, knockdown of bPIX alone was sufficient to suppress
Rac1 and Cdc42 activity and inhibited cell migration and the
metastatic ability of CL1-5 cells (Figures S6A, S7A, and
S7D–S7G). Furthermore, overexpression of aPIX or bPIX
increased the migration ability of CL1-0 cells (Figure S7B).
Consistently, shRNA specific for aPIX or bPIX decreased the
migration ability of Naa10p knockdown AGS cells (Figure 6C).
These data suggested that aPIX and/or bPIX are important for
Naa10p to regulate small G protein activity and cell migration.
Previous studies have shown that GIT proteins are involved in
guiding PIX proteins to the cell periphery or focal adhesions
where they activate Rac1 or Cdc42 (Koh et al., 2001). In order
to evaluate the importance of GIT proteins in our cell model,
we used shRNAs to knock down GIT1 and GIT2 separately
and estimated the levels of GTP-bound Rac1/Cdc42. Both
GIT1 and GIT2 were expressed in CL1-5 cells and affected the
GTP-bound level of Rac1/Cdc42 and cell migration when dimin-
ished by shRNAs. Furthermore, simultaneous knockdown of
both GITs further suppresses the activity of Rac1/Cdc42 (Fig-
ure S6B) and cell migration to a more significant level
A B
C D
E
F
Figure 5. Naa10p Associates with aPIX and bPIX
(A) 293T cells were transfected with Naa10-V5 together
with HA-aPIX, HA-bPIX, or HA-TIAM1 as indicated. Cell
lysates were immunoprecipitated with anti-V5 or normal
mouse IgG antibody, respectively.
(B) Endogenous interaction between bPIX and Naa10p.
AGS cell lysates were immunoprecipitated with immobi-
lized anti-bPIX or anti-Naa10p protein A beads and immu-
noblotted with anti-bPIX and anti-Naa10p antibody.
(C) Purified recombinant GST-Naa10p was incubated with
[35S]-aPIX or [35S]-bPIX in the presence of glutathione-
Sepharose. The washed precipitates were subjected to
SDS-PAGE, and [35S]- aPIX or [35S]-bPIX were detected
by autoradiography.
(D) Schematic diagram represents expressed fragments
of Naa10p and bPIX. Naa10p containing acetyltransferase
domain (Ac) and bPIX containing SH3, Dbl (DH), and
Pleckstrin (PH) homology domains, a Cat (Cool-associ-
ated tyrosine phosphosubstrate)/Git (G protein-coupled
receptor kinase interactor)-binding (GBD) domain and
a leucine zipper (LZ).
(E) HA-bPIX expressed in 293T cells was incubated with
GST-fused Naa10p fragments in the presence of gluta-
thione-Sepharose. The washed precipitates were sub-
jected to SDS-PAGE, followed by immunoblotting with
anti-HA antibody. Protein loading and purities were
confirmed by Coomassie blue staining.
(F) HA-tagged fragments of bPIX as indicated were coex-
pressed with Naa10-V5 in 293T cells and immunoprecipi-
tated with anti-V5 antibody. The presence of associated
bPIX protein was assessed by immunoblotting using
anti-HA antibody.
(A–F) In each experiment, 10% of each lysate was used as
input. See also Figure S5.
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and GIT2 promote Rac1/Cdc42 activation and cell migration in
CL1-5 cells. Since Naa10p binds to the GIT-binding domain of
PIX proteins, we evaluated whether Naa10p could disrupt the
association between aPIX or bPIX and GIT proteins. Our results
indicated that the ability of GST-bPIX to associate with Flag-
tagged GIT1 and GIT2 was decreased in the presence of V5-
tagged Naa10p (Figure 6D) or Naa10p-R82A (Figure S6C).
However, the ability of GST-bPIX to associate with HA-tagged
PAK1 or PAK3, which interacts with the SH3 domain of the PIX
proteins, was not changed in the presence of Naa10p or
Naa10p-R82A (Figure S6D). Moreover, GST-Naa10p lost its
ability to associate with Myc-tagged aPIX in the presence of
Flag-tagged GIT1 (Figure S6E). Consistent with these findings,
the amount of bPIX-associated GIT1 was higher in low
Naa10p-expressing CL1-5 cells compared with the high
Naa10p-expressing CL1-0 cells (Figure 6E). This competition
could also be observed in the cell migration ability, where over-
expression of Flag-tagged GIT1, but not the Myc-tagged PAK1,
increased the migration ability of Naa10p-overexpressing CL1-5
cells (Figure 6B). Similarly, shRNA specific for GIT1 reduced the
migration ability of Naa10p knockdown AGS cells (Figure 6C). To
determine whether Naa10p could influence the localization of
aPIX and bPIX, we evaluated the distribution of endogenous
bPIX by immunofluorescence staining analysis. bPIX wasCdetected in the puncta of membrane protrusions in A549 cells,
but was dramatically decreased in cells with Naa10p-V5 expres-
sion (Figure 6F). Furthermore, transfection of shRNAs against
aPIX or bPIX in Naa10p-knockdown AGS cells resulted in
a less protrusive phenotype. Ectopic overexpression of aPIX or
bPIX in CL1-5/Naa10 cells resulted in a more protrusive pheno-
type, similar to that observed in the CL1-5 control cells (Fig-
ure S6G). We also noted a slight decrease of bPIX in the
membrane fraction of CL1-5/Naa10 cells (Figure 6G). Similarly,
a substantial portion of bPIXwas detected in themembrane frac-
tion of CL1-0 cells when Naa10p was depleted (Figure S6F).
These data suggest that Naa10p competes against GIT for
binding to PIX, preventing the translocation of PIX to the plasma
membrane. This results in decreased Rac1/Cdc42 activation
and decreased cell mobility.
To elucidate the role of Naa10p and PIX proteins inmetastasis,
we generated GFP- and luciferase-expressing CL1-5 cells
(CL1-5GL) and transfected them with an empty vector,
Naa10p-V5 alone, or in combination with aPIX or bPIX (Fig-
ure 7A). Cells were injected into the tail vein of NOD-SCID
mice and the mice were monitored for the formation of lung
tumors. Four weeks after injection, the number of lungmetastatic
nodules was determined by bioluminescence activity. Large
numbers of metastatic nodules were observed in animals in-
jected with control CL1-5GL cells, whereas few nodules wereancer Cell 19, 218–231, February 15, 2011 ª2011 Elsevier Inc. 225
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Figure 6. Naa10p Disrupts the Interaction between PIX and GIT to Inhibit Cdc42/Rac1 Activation and Cell Migration
(A) 293T cells were transfected with either control vector or HA-bPIX alone or together with different amount of Naa10-V5 or R82A-V5. Cell lysates were harvested
and subjected to GST-PBD pull-down assay. The amounts of GTP-Cdc42/Rac1 were analyzed by densitometer.
(B) CL1-5 cells were transfected with control vector, Naa10-V5, HA-aPIX, HA-bPIX, Flag-GIT1, and Myc-PAK1 as indicated and subjected to transwell migration
assay. The fold difference represents the mean of triplicate experiments compared with control cells. *p < 0.05 as compared with control cells. #p < 0.05 as
compared with Naa10-V5 transfected CL1-5 cells.
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AC D E
B Figure 7. Expression of PIX Proteins
Rescued Cancer Cell Metastatic Ability
Suppressed by Naa10p
(A) Establishment of CL1-5/luciferase cells stably
expressing Naa10-V5 and Naa10-V5 plus aPIX or
bPIX. Expression of Naa10p was detected using
a chicken anti-Naa10p polyclonal antibody
(ab51787, Abcam). aPIX and bPIX were detected
using a rabbit anti-PIX polyclonal antibody
(AB3829, Chemicon).
(B) Representative photographs of lungs taken
28 days after tail vein injection of the cells into
NOD-SCID mice. Left panel: Photon counting
analysis of lung nodules was performed after inoc-
ulation with luciferin. Middle and right panel:
Representative lungs and H & E staining of lung
metastatic tumors in each group are shown. Scale
bar, middle panel: 5 mm, right panel: 2 mm.
(C) Number of surface metastases in lungs of mice
(n = 8–9 per group) 4 weeks after tail vein injection
of cells. *p < 0.05.
(D) Quantitative photon counting analysis of lung
metastases in each group. *p < 0.05.
(E) Schematic representation depicting the effects
of Naa10p on PIX localization and Cdc42/Rac1
activation. In migrating cells, PIX colocalizes with
GIT/Paxillin at focal adhesions. This allows PIX to
activate Cdc42/Rac1. Active Cdc42/Rac1 induces
actin dynamic change, contributing to cell migra-
tion. Naa10p competes with GIT binding to PIX
and sequesters PIX from focal adhesion, blocking
Cdc42/Rac1 activation and cell migration. See
also Figure S7.
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Naa10p Suppresses Cancer Metastasis through PIXdetectable in animals injected with Naa10p-V5-expressing cells.
As predicted, overexpression of aPIX or bPIX increased the
number of metastatic nodules in ARD-V5-expressing CL1-5GL
cells (Figure 7B). Quantitative data (the number of surface lung
metastases and level of photon radiance), shown in Figures 7C
and 7D, confirmed these findings. Together this indicates that
the Naa10p-mediated regulation of PIX proteins is an important
event in the formation of lung metastasis.
DISCUSSION
Tumor metastasis is the main cause of cancer-related death.
Identifying genes regulating cell migration and metastasis is
crucial to the understanding of this process. In recent years,
the Rac1 and Cdc42 pathways have been extensively studied(C) Cell migration of AGS cells infected with lentivirus carrying shRNA for eithe
percentage of migrated cells compared with cells receiving shRNA for luciferase
specific antibodies. *p < 0.05.
(D) 293T cell lysates containing Flag-GIT1, Flag-GIT2, or Naa10-V5 were incuba
were washed and subjected to SDS-PAGE. GIT1, GIT2, and Naa10p were detecte
for each group.
(E) bPIX-associated GIT1 were examined in CL1-0 and CL1-5 cells. Cell lysates
antibody.
(F) Representative photographs for immunofluorescence staining of endogeno
indicate bPIX-enriched cell protrusions. Nuclei were counterstained with DAPI. S
(G) Subcellular fractionation was performed with the CNM compartmental protein
lular distribution of Naa10p and bPIX was determined by immunoblotting. EGFR
marker. M, membrane fraction; C, cytosolic fraction. Error bars indicate SD. See
Cin the context of metastasis. The complex interplay between its
regulators and effectors results in the establishment of mem-
brane protrusions and eventual cell migration. The PIX family of
proteins has an important function in this process, acting as
aGEF and scaffold protein between Rac1/Cdc42 and their effec-
tors. We have identified Naa10p as a regulator of PIX and
suppressor of tumor cell migration and/or metastasis. We found
that Naa10p and GIT bind to the same site of the PIX protein. In
the presence of Naa10p, GIT proteins fail to bind to the PIX
proteins, disrupting the translocation of PIX to the plasma
membrane (Figure 7E). Therefore, high expression of Naa10p
restricts cell mobility and decreases the possibility of cancer
cell metastasis in vivo.
Recently, Lee et al. have used Naa10p antibody to analyze
a small cohort of lung adenocarcinoma and observedr Naa10p or luciferase, or together with shRNA for aPIX, bPIX, or GIT1. The
is shown. The knockdown efficiency was shown by western blot analysis using
ted with either GST or GST-bPIX as indicated. Left panel: Pull-down products
d by immunoblotting using specific antibodies. Right panel: 10% loading input
were immunoprecipitated with anti-bPIX and immunoblotted with anti-GIT1
us bPIX in A549 cells stably expressing Naa10-V5 or control vector. Arrows
cale bar, 10 mm.
extraction kit (K3012010, BioChain Institute, Inc., Hayward, CA). The subcel-
was used as the membrane marker, and a-Tubulin was used as the cytosolic
also Figure S6.
ancer Cell 19, 218–231, February 15, 2011 ª2011 Elsevier Inc. 227
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(Lee et al., 2010). However, since Naa10p is known to have
several variants and homolog (Bilton et al., 2006), it is possible
that Lee’s antibody raised against full-length Naa10p may also
recognize these Naa10p family proteins due to their highly
conserved acetyltransferse motif. Here, we used a specific anti-
body which recognizes the C-terminal region of Naa10p (aa 155–
235) to analyze 318 lung tumor specimens and found a reverse
correlation with patient overall survival (p = 0.0044) and
disease-free survival (p = 0.0039). We have also observed
a significant inverse correlation of Naa10p expression and
patient survival in female adenocarcinoma population. However,
Naa10p expressions are not significantly correlates with patient
survival of male or SCC patients (Figures S1C and S1D). The
inconsistent results may be due to the antibody specificity
and/or the different compositions of patient cohorts. Collec-
tively, our results based on specific antibody and multiple lines
of clinical evidence support that Naa10p is a suppressor of tumor
progression.
N-a-acetylation is one of the most common post-translational
modifications in eukaryotes. The major N-a-acetyltransferase in
human cells is composed of Naa10p and Naa15p (Polevoda
and Sherman, 2000). There have also been reports indicating
that Naa10p can function as an N-3-acetyltransferase (Lim
et al., 2006, 2008). However, it remains questionable as to
whether one enzyme could catalyze both N-a- and N-3-acetyla-
tion. Here, we report that Naa10p can exert its function indepen-
dent of its enzymatic activity. We found that Naa10p suppressed
cellmigration in the absenceofNaa15p. UnlikeNaa10pdepletion
by siRNAs or shRNA, Naa15p depletion by shRNA specific for
Naa15p did not affect cell migration (data not shown). Further-
more, a Naa10p mutant without acetyl-CoA binding ability
retained its migration inhibiting capability. We propose that
Naa10p regulates cell migration by interacting with the PIX family
of proteins. Although the interactionwith PIX occurswith the ace-
tyltransferase domain of Naa10p, we did not observe any detect-
able level of acetylated bPIX in cells under the influence of
Naa10p-V5 or in the presence of specific shRNA against it, indi-
cating that bPIXmay not be anN-3-acetylation target of Naa10p.
Our data suggest that Naa10p regulates cell migration through
the Rac1/Cdc42 pathway. PIX is a well-studied regulator as
a GEF of both Rac1 and Cdc42. Our current hypothesis is that
Naa10p binds and regulates the cellular localization of PIX
thereby preventing the activation of Rac1/Cdc42. In addition to
acting as a GEF, PIX can function as scaffold protein within the
focal adhesion complex. Previous studies have shown that
PAK, the major component of the Rac1/Cdc42 pathway can
bind to the SH3 domain of PIX (Manser et al., 1998). Hence,
PIX does not only activate PAK, it plays a central role in bringing
PAK to the focal adhesion complex. Interestingly, PIX has been
shown to activate PAK independently of Rac1/Cdc42 activity,
possibly through the interaction of the other members of the
focal adhesion complex. In addition to PAK, PIX can associate
with GIT, another scaffold protein of the focal adhesion complex.
GIT function as the link between paxillin and the PIX complex
(Zhao et al., 2000). The GIT family consists of two highly similar
proteins: GIT1 and GIT2 (Premont et al., 1998, 2000). Both
bind directly to paxillin, and thereby localized to focal adhesions.
Our result indicates that both GIT proteins may be involved in228 Cancer Cell 19, 218–231, February 15, 2011 ª2011 Elsevier Inc.Rac1/Cdc42 activation and cell migration potentials in a similar
manner, as the depletions of both GIT1 and GIT2 suppress
GTPase activation and reduces cell migration more significantly
than depletion of either one alone (Figure S6B). The underlying
mechanism is speculated to be that GIT1 and GIT2 could sub-
stitute for each other in directing PIX proteins to focal adhesions
through interaction with paxillin. Upon depletion of one GIT
proteins, the other one is still capable of directing localization
of PIX proteins. We propose that Naa10p competes with GIT
for the binding of PIX. Since this interaction is required to bring
PIX to the focal adhesion, overexpression of Naa10p reduces
the amount of PIX at the cellular membrane (Figures 6F and
6G), prevents the activation of Cdc42/Rac (Figure 4A) and
decrease cell migration.
Although our data suggest GBD domain is the primary site for
Naa10p interaction, the other domains or other PIX-associated
protein may also affect the interaction between Naa10p and
PIX. Given that PH domain-deleted bPIX showed a reduced
affinity to Naa10p (Figure 5F), it is possible that proteins associ-
ated with PH domain may help providing proper structure for
Naa10p docking at the GBD domain. Similar situations may
occur at other domains, since SH3 and LZ domain deletion
also seems to affect the interaction between aPIX and Naa10p
(Figure S5D). However, our results suggest that Naa10p binding
only affects the interaction between GIT1/2 and PIX but not
PAK1/3, which interacts with PIX at the SH3 domain. This obser-
vation supports that the GBD domain was the major site, even
not the only site, for the Naa10p interaction.
The role of Naa10p in cell migration is likely to be complex.
Although our study indicates an acetylation-independent mech-
anism of Naa10p in regulating cell mobility, we cannot rule out
the acetylation-dependent mechanism. As shown in
Figure S2F, the Naa10p-R82A mutant may still have some re-
maining function to acetylate some other specific proteins that
participate in cell mobility control. Recently, myosin light chain
kinase (MLCK) was found to be another Naa10p target (Shin
et al., 2009). Naa10p acetylated MLCK and suppressed its
activity, which resulted in decreased cell mobility. Interestingly,
myosin light chain is one of the targets of the PAKs (Chew
et al., 1998; Coniglio et al., 2008), which suggests a possible
involvement of the PIX-GIT-Paxillin complex in this process.
PAKs could either be directly activated by Rac1 and Cdc42
binding (Knaus et al., 1998) or induced by GIT-PIX-PAK complex
formation (Loo et al., 2004). Our data suggest that both of these
processes can be suppressed by Naa10p. A study by Shin et al.
(2009) and our findings emphasize the importance of Naa10p as
an important regulator of cell migration and metastasis.
Naa10p was found to express in tumor tissues. However, the
role of Naa10p in tumorigenesis is controversy. Although
growth-promoting activity associated with Naa10p function is
well in line with published evidence, there is also report sug-
gested that different Naa10 siRNAs used may result in complete
opposite effect (Yi et al., 2007). Lee et al. reported that Naa10p
promotes tumorigenesis in lung cancer cells, and suggest that
Naa10p is helping the DNMT to silence tumor suppressors.
However, Naa10p maybe act through different mechanism in
normal epithelium and tumor cells. Recently, Naa10p has been
shown to suppress tumorigenesis through acteylating TSC2
and induce autophagy of tumor cell (Kuo et al., 2010). Kuo
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Naa10p Suppresses Cancer Metastasis through PIXet al. and our in vivo results had also shown significant smaller
tumor size of xenografts in Naa10p overexpression cells (Fig-
ure S3A). In line with our clinical results (Table 1), Kuo et al.
had also observed a significant lower Naa10p expression in
breast cancer specimens and lymph nodemetastases. Although
the exact roles of Naa10p in tumorigenesis and/or tumor
progression remain to be elucidated, we showed here that
Naa10p act as a metastasis suppressor during tumor
progression.
In conclusion, we have shown that Naa10p is a good prog-
nostic factor whose overexpression is associated with increased
survival and decreased lymph nodemetastasis.We propose that
Naa10p can act as a tumor migration and/or metastasis
suppressor by binding to the GIT binding domain of PIX. Our
data indicate that Naa10p has the opposite effect of GIT to
prevent membrane protrusion, cell migration, and lymph node
metastasis.EXPERIMENTAL PROCEDURES
Immunohistochemistry
Tissues utilized were obtained with informed consent and the study was con-
ducted under the approval of the Institutional Review Boards of National
Taiwan University Hospital and Kaohsiung Medical University Hospital. Tissue
was fixed in formalin and subsequently was dehydrated, paraffin embedded,
and sectioned. Tissue sections were immunostained as described previously
(Su et al., 2004). A four-point staining intensity scoring system was devised for
determining the relative expression of Naa10p in cancer specimens; the stain-
ing intensity score ranged from 0 (no expression) to 3 (maximal expression).
The results were classified into two groups according to both the intensity
and extent of staining: in the low-expression group, either no staining was
present (staining intensity score = 0) or positive staining was detected in less
than 10% of the cells (staining intensity score = 1), and in the high-expression
group, positive immunostaining was present in 10%–25% (staining intensity
score = 2) or more than 25% of the cells (staining intensity score = 3). All of
the immunostaining results were reviewed and scored independently by two
pathologists. The histological diagnosis of lung adenocarcinoma was made
according to the recommendations of the World Health Organization (Gibbs
and Thunnissen, 2001). Tumor size, local invasion, lymph node metastasis,
and final disease stage were determined as described previously (Sobin and
Fleming, 1997). Follow-up of patients was carried out up to 200 months.
siRNA Transfection
On-Target plus siRNAs for human Naa10p, as well as Risc-free control siRNA,
were from Dharmacon Research (Lafayette, CO). Cells were transfected with
siRNAs as indicated for 18–24 hr using Lipofectamine 2000 (Invitrogen,
Carlsbad, CA) followed by a change of media. Two to three days after siRNA
transfection, cells were subjected to migration assays. Reduced expression
by siRNA was monitored by immunoblotting with Naa10p antibody.
Two-Chamber Migration Assay
Cell mobility was determined using themodified two-chamber migration assay
(8 mm pore size, BD Biosciences, Bedford, MA) according to the manufac-
turer’s instructions. About 2 3 104 cells were seeded into the upper chamber
and allowed to migrate into the lower chamber for 18–24 hr. Cells in the upper
chamber were carefully removed using cotton buds and cells at the bottom of
the membrane were fixed and stained with crystal violet 0.2%/methanol 20%.
Quantification was performed by counting the stained cells.
Immunofluorescence Microscopy
Cells were grown on coverslips and fixed in 4% paraformaldehyde, permeabi-
lized, and stainedwith primary antibodies followed by secondary FITC or Alexa
555-conjugated mouse or rabbit antibodies. F-actin was detected with
FITC-phalloidin (Invitrogen). Slides were examined and photographed usingCa Zeiss Axiophot fluorescence microscope. Nuclei were counterstained with
40,6-diamino-2-phenylindole (DAPI).
Immunoprecipitation
Cells were lysed by brief sonication (3 3 1 s pulses) in coimmunoprecipitation
buffer (20 mM Tris [pH 8.0], 150 mM NaCl, 1 mM EDTA, 0.5% NP-40
supplemented with protease [Complete, Roche] inhibitors). Lysates were
centrifuged for 20 min at 10,000 3 g and the resulting supernatant was pre-
cleared by incubation with immobilized Protein A/G gel (25 ml; Pierce, Rock-
ford, IL) for 1 hr at 4C. The precleared supernatant was subjected to overnight
immunoprecipitation using the indicated antibodies or control IgG antibodies
at 4C. The next day, protein complexes were collected by incubation with
25 ml of immobilized Protein A/G gel for 1 hr at 4C. The collected protein
complexes were washed four times with coimmunoprecipitation buffer and
eluted by boiling in protein sample buffer under reducing conditions, after
which proteins were resolved on SDS–PAGE and analyzed by western blot.
Spontaneous Metastasis Assay
Seven female BALB/c mice were fat pad injected with 4T1/Luc cells overex-
pressing Naa10p, Naa10p-R82A, or control vector (1 3105 cells with Matrigel
at 5 mg ml-1 of PBS in a volume of 200 ml). Tumor growth was monitored twice
a week by Vernier caliper measurement of two perpendicular tumor diameters
(L and W). Tumor volume was calculated using the formula LW2/2. After the
tumor volume exceeded 1 cm3, the primary tumors were surgically removed.
Lungs were isolated 2 weeks after the surgery and examined. The tumor colo-
nies were counted 3weeks later. All animal work was performed in accordance
with protocols approved by the Institutional Animal Care and Use Committee
of the College of Medicine, National Taiwan University.
Statistical Analysis
Results are expressed as the mean ± SD. We utilized a two-tailed, unpaired
Student’s t test for all pair-wise comparisons. Survival curves were obtained
using the Kaplan-Meier method.
p values less than 0.05 were considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at doi:10.1016/j.
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